Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Longevity
Singapore-based healthcare firm expands into stem cell therapies and longevity as demand for proactive aging solutions grows across Asia. Singapore-based…
Epigenetic rejuvenation gears up for the clinic, the power of plasma exchange and the final interview with a longevity biotech…
Northwestern researchers unveil the most detailed 3D genome maps, revealing how DNA folding regulates genes and disease risk. For decades,…
A collaborative study reports a multi-target nanoparticle therapy that dramatically improves neuron survival in Alzheimer’s models. Alzheimer’s disease remains one…
European Commission wants to speed up biotech, fix device bottlenecks and cut heart disease, while keeping Europe competitive in global…
Healthspan as a universal right, the need for new regulation, the age of mitochondrial therapies and 7 shifts to accelerate…
The approval marks a milestone for GLP-1 drugs, expanding access beyond injections as Novo Nordisk prepares for a competitive obesity…
Long-term data suggest newly approved therapy can change trajectory of a rare inherited form of ALS, with sustained gains in…
Study links statin use to slower cognitive decline in Alzheimer’s patients, prompting renewed interest in repurposing common heart drugs. Long…
Longevity-linked enzyme shown to regulate brain metabolism, opening drug and biomarker opportunities for aging-related neurological disease. A newly identified role…